Galapagos Says Glaxo Invests Further 4.4 Mln

Galapagos NV said it has expanded its multiyear osteoarthritis alliance with GlaxoSmithKline after the pharmaceuticals giant invested a further 4.4 mln eur in the Belgian biotech company.
Hemscott